Skip to content

Prediction of Femoral Revascularization Quality Using the Somatic NIRS Signal

Prediction of Femoral Revascularization Quality Using the Somatic NIRS Signal

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02337920
Acronym
TEA-NIRS
Enrollment
31
Registered
2015-01-14
Start date
2015-02-28
Completion date
2016-02-29
Last updated
2017-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Vascular Surgery - Femoral Artery Endarteriectomy

Brief summary

Despite effective femoral artery endarteriectomy, patients with occlusive arteritis may need complementary stenting of revascularization procedures within the 2 years after the primary surgery because of a poor blood supply in their lower limb extremity. The Near infrared spectrophotometry (NIRS) is a non-invasive monitoring of the brain or tissue oxygenation and provide information on the quality of the local oxygen supply. The aim of our observational study is to correlate the intraoperative NIRS variations at the calf and the soles and the one-year evolution of the arteritis.

Interventions

None listed

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing unilateral femoral endarteriectomy

Exclusion criteria

* emergency surgery, allergy to adhesive glues, skin abnormalities of the operated leg, multiple associated revascularization procedures other than endarteriectomy

Design outcomes

Primary

MeasureTime frame
Relationship between the Maximum NIRS difference before and during the femoral artery clamping and the increase of walking perimeterChange - One month, six months and one year after the surgery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026